Cytokines and nervous system: relationship with schizophrenia

Authors

  • Luis Javier Ramirez-Jirano <p>Instituto Mexicano del Seguro Social, Centro de Investigaci&oacute;n Biom&eacute;dica de Occidente, Divisi&oacute;n de Neurociencias, Neuroinmunomodulaci&oacute;n. Guadalajara, Jalisco, M&eacute;xico</p> http://orcid.org/0000-0002-2299-6721
  • Sandra Fabiola Velasco-Ramírez <p>Universidad de Guadalajara, Centro Universitario de Ciencias Exactas e Ingenier&iacute;as, Departamento de Qu&iacute;mica. Guadalajara, Jalisco, M&eacute;xico</p>
  • Gloria Aleida Pérez-Carranza <p>Instituto Mexicano del Seguro Social, Centro de Investigaci&oacute;n Biom&eacute;dica de Occidente, Divisi&oacute;n de Neurociencias, Neuroinmunomodulaci&oacute;n. Guadalajara, Jalisco, M&eacute;xico</p>
  • Carolina Domínguez-Díaz <p>Instituto Mexicano del Seguro Social, Centro de Investigaci&oacute;n Biom&eacute;dica de Occidente, Divisi&oacute;n de Neurociencias, Neuroinmunomodulaci&oacute;n. Guadalajara, Jalisco, M&eacute;xico</p>
  • Oscar Kurt Bitzer-Quintero <p>Instituto Mexicano del Seguro Social, Centro de Investigaci&oacute;n Biom&eacute;dica de Occidente, Divisi&oacute;n de Neurociencias, Neuroinmunomodulaci&oacute;n. Guadalajara, Jalisco, M&eacute;xico</p>

Keywords:

Schizophrenia, Cytokines, Neurotransmitter Agents, Inflammation, Nervous System

Abstract

Schizophrenia is a heterogeneous disorder of mental symptoms and alterations, characterized by presenting abnormal ideas and perceptions, in which the individual loses contact with reality as a result of a complex neuropsychological disorganization, which affects the affective, intellectual and behavioral functioning; as well as inducing a significant social dysfunction.

The etiology of schizophrenia is extremely complex, and is not very clear yet; it is believed to be the result of the combination of genetic factors and the environment.

Numerous neurotransmitters have been implicated in this disease, as is the case of dopamine, serotonin and glutamate.

The role of the inflammatory process in the pathogenesis of schizophrenia has been postulated, where a prenatal immune "challenge" during the second trimester of pregnancy can be key to the development of the disease.

Some of the pro-inflammatory cytokines (TNF-alpha, IL-1beta and IL-6) play a key role in the processes of modulation of the nervous system functions related to affective, emotional and social alterations in subjects with schizophrenia.

The mechanisms associated with inflammation and the anti-inflammatory defense system that may be associated with the development of schizophrenia are still unknown.

This review was intended to address schizophrenia, in regards to the mechanisms associated with inflammation and the anti-inflammatory defense system in its development.

Downloads

Download data is not yet available.

Author Biography

  • Luis Javier Ramirez-Jirano, <p>Instituto Mexicano del Seguro Social, Centro de Investigaci&oacute;n Biom&eacute;dica de Occidente, Divisi&oacute;n de Neurociencias, Neuroinmunomodulaci&oacute;n. Guadalajara, Jalisco, M&eacute;xico</p>

    Químico Farmacéutico Biólogo egresado de la Universidad de Colima, con grados de Maestro y Doctor en Genética Humana por la Universidad de Guadalajara, realice una estancia posdoctoral en el Doctorado en Ciencias Biomédicas. Así mismo tengo un Diplomado en Formación Docente, auspiciado por el Instituto Nacional de Salud Pública.

    Actualmente Laborando en el Centro de Investigación Biomédica de Occidente y Miembro del Sistema Nacional de Investigadores Nivel 1.

    Profesor de Genética Humana, Bioestadística y Metodología de la Investigación, a nivel licenciatura y posgrado, involucrado en diversos proyectos de investigación desde 1997, relacionados con shock endotóxico, Daño Oxidativo, aspectos moleculares de Papilomavirus Humano, Dengue, Enfermedad de Chagas, Leptospirosis, Hantavirus, Influenza A H1N1, Modelos Animales, Esclerosis Múltiple y Encefalitis Autoinmune Experimental. También he impartido conferencias y cursos, tanto en congresos nacionales como internacionales. Revisor de tesis de Maestría y Doctorado, así como también en la revisión de protocolos sometidos para financiamiento.

References

Ferrero-Rodríguez LM, Pérez-Magín IM, Gómez-Padrón EI, Loynaz-Fernández CS, Rodríguez-Rodríguez A. Algunas características anatómicas del encéfalo del esquizofrénico. Rev Cubana Invest Biomed. 2004;23(3):163-8.

 

Onstad S, Skre I, Torgersen S, Kringlen E. Twin concordance for DSM-III-R schizophrenia. Acta Psychiatr Scand. 1991;83(5):395-401.

 

Solter V, Thaller V, Bagarić A, Karlović D, Crnković D, Potkonjak J. Estudio de la esquizofrenia comórbida con la adicción alcohólica. Eur J Psychiat. 2004;18(1):14-22.

 

Hoff AL, Kremen WS. Neuropsychology in schizophrenia: an update. Current Opinion in Psychiatry. 2003;16(2):149-55.

 

Kaymaz N, van Os J. Murray et al. (2004) revisited: is bipolar disorder identical to schizophrenia without developmental impairment? Acta Psychiatr Scand. 2009;120(4):249-52. DOI: https://doi.org/10.1111/j.1600-0447.2009.01472.x

 

Dean L. Schizophrenia. En: Pratt V, McLeod H, Rubinstein W, Dean L, Kattman B, Malheiro A et al. Eds. Medical Genetics Summaries. Bethesda (MD), USA: National Center for Biotechnology Information; 2012. Última actualización, 6 de febrero de 2017. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK62008/

 

Jenkins TA. Perinatal complications and schizophrenia: involvement of the immune system. Front Neurosci. 2013;7:110. DOI: 10.3389/fnins.2013.00110

 

Brown AS, Patterson PH. Maternal infection and schizophrenia: implications for prevention. Schizophr Bull. 2011;37(2):284-90. DOI: https://doi.org/10.1093/schbul/sbq146

 

Alvarez MJ, Roura P, Osés A, Foguet Q, Solà J, Arrufat FX. Prevalence and clinical impact of childhood trauma in patients with severe mental disorders. J Nerv Ment Dis. 2011;199(3):156-61.

 

O'Tuathaigh CM, Babovic D, O'Sullivan GJ, Clifford JJ, Tighe O, Croke DT, et al. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience. 2007;147(1):18-27. DOI: https://doi.org/10.1016/j.neuroscience.2007.03.051

 

Takano H. Cognitive Function and Monoamine Neurotransmission in Schizophrenia: Evidence From Positron Emission Tomography Studies. Front Psychiatry. 2018;9:228; 1-8. DOI: https://doi.org/10.3389/fpsyt.2018.00228

 

Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S. The immunoregulatory role of dopamine: an update. Brain Behav Immun. 2010;24(4):525-8. DOI: https://doi.org/10.1016/j.bbi.2009.10.015

 

Merritt K, McGuire P, Egerton A. Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis. Front Psychiatry. 2013;4:151. DOI: https://doi.org/10.3389/fpsyt.2013.00151

 

White R, Krämer-Albers EM. Axon-glia interaction and membrane traffic in myelin formation. Front Cell Neurosci. 2014;7:284. DOI: https://doi.org/10.3389/fncel.2013.00284

 

Yao JK, Keshavan MS. Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal. 2011;15(7):2011-35.

 

Müller N. The role of anti-inflammatory treatment in psychiatric disorders. Psychiatr Danub. 2013;25(3):292-8.

 

Ellman LM, Deicken RF, Vinogradov S, Kremen WS, Poole JH, Kern DM, et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res. 2010;121(1-3):46-54. DOI: https://doi.org/10.1016/j.schres.2010.05.014

 

Dickerson DD, Bilkey DK. Aberrant neural synchrony in the maternal immune activation model: using translatable measures to explore targeted interventions. Front Behav Neurosci. 2013;7:217. DOI: https://doi.org/10.3389/fnbeh.2013.00217

 

Hanson DR, Gottesman II. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Genet. 2005;6:7. DOI: https://doi.org/10.1186/1471-2350-6-7

 

Barron H, Hafizi S, Andreazza AC, Mizrahi R. Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk. Int J Mol Sci. 2017;18(3). DOI: https://doi.org/10.3390/ijms18030651

 

Meyer U. Anti-inflammatory signaling in schizophrenia. Brain Behav Immun. 2011;25(8):1507-18. DOI: https://doi.org/10.1016/j.bbi.2011.05.014

 

Markham JA, Koenig JI. Prenatal stress: role in psychotic and depressive diseases. Psychopharmacology (Berl). 2011;214(1):89-106. DOI: https://doi.org/10.1007/s00213-010-2035-0

 

Canetta SE, Brown AS. Prenatal Infection, Maternal Immune Activation, and Risk for Schizophrenia. Transl Neurosci. 2012;3(4):320-7. DOI: https://doi.org/10.2478/s13380-012-0045-6

 

Schmitz T, Chew LJ. Cytokines and myelination in the central nervous system. TheScientificWorldJOURNAL. 2008;8:1119-47. DOI: https://doi.org/10.1100/tsw.2008.140

 

Smyth AM, Lawrie SM. The neuroimmunology of schizophrenia. Clin Psychopharmacol Neurosci. 2013;11(3):107-17. DOI: https://doi.org/10.9758/cpn.2013.11.3.107

 

Kästner A, Grube S, El-Kordi A, Stepniak B, Friedrichs H, Sargin D, et al. Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia. Mol Med. 2012;18:1029-40. DOI: https://doi.org/10.2119/molmed.2012.00190

 

Roussos P, Haroutunian V. Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities. Front Cell Neurosci. 2014;8:5. DOI: https://doi.org/10.3389/fncel.2014.00005

 

Michel M, Schmidt MJ, Mirnics K. Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol. 2012;72(10):1277-87. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435446/

 

Poon VY, Choi S, Park M. Growth factors in synaptic function. Front Synaptic Neurosci. 2013;5:6. DOI: https://doi.org/10.3389/fnsyn.2013.00006

Published

2019-10-16

Issue

Section

Review Article